EP3000467
MEÐFERÐARÁFORM SEM NOTAR NERATINIB VIÐ BRJÓSTAKRABBAMEINI
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
24.3.2010EP published:
1.3.2023EP application number:
15188350.1
EP translation filed:
16.3.2023Grant published:
15.4.2023EPO information:
European Patent Register
Max expiry date:
23.3.2030Expiry date:
23.3.2027Next due date:
31.3.2027
Title in English:
TREATMENT REGIMEN UTILIZING NERATINIB FOR BREAST CANCERLanguage of the patent:
English
Timeline
Today
24.3.2010EP application
1.3.2023EP Publication
16.3.2023Translation submitted
15.4.2023Registration published
23.3.2027Expires
Owner
Name:
Wyeth LLCAddress:
66 Hudson Boulevard East, New York, NY 10001-2192, US
Inventor
Name:
BERKENBLIT, AnnaAddress:
Needham, MA 02494, US
Name:
BINLICH, FlorenceAddress:
F-92410 Ville D'Avray, FR
Name:
GOSS, PaulAddress:
Wellesley, MA Massachusetts 02482, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
166796 PDate:
6.4.2009Country:
US
Supplementary protection
SPC number:
SPC436
Classification
Categories:
A61K 31/4709, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 14
Paid: 31.3.2023
Expires: 23.3.2024
Payer: Árnason Faktor ehf.
Number: 15
Paid: 14.2.2024
Expires: 23.3.2025
Payer: Árnason Faktor ehf.
Number: 16
Paid: 14.2.2025
Expires: 23.3.2026
Payer: Árnason Faktor ehf.
Number: 17
Paid: 9.3.2026
Expires: 23.3.2027
Payer: Árnason Faktor ehf.